Abstract
Bone morphogenetic proteins (BMPs) encompass a large subgroup of evolutionary conserved, secreted signaling molecules belonging to the TGF-β superfamily. In contrast to that suggested by their name, BMP function is not restricted to the skeleton. Recent studies in several organisms have revealed multiple roles for BMPs during embryogenesis where they are involved in early embryonic pattering, gastrulation, tissue induction and differentiation [1]. BMP signaling activity is regulated at multiple levels (Fig. 1A). In the intracellular space multiple regulatory proteins control BMP signaling after initial BMP receptor activation. In the extracellular space BMP antagonists such as Noggin, Follistatin and related proteins, Gremlin and other members of the Dan family, Chordin and its relatives along with Twisted Gastrulation (Tsg), all regulate the ability of BMPs to engage the BMP receptors. Studies on flies and lower vertebrates have led to the concept that these extracellular interactions result in the formation of BMP activity gradients, which in turn provide positional cues to the cells that encounter them [2–4]. Although direct evidence for the operation of such activity gradients is missing in higher vertebrates, orthologs for all antagonists do exist. In addition, there are data pointing to neighboring or overlapping domains of expression between BMPs and their antagonists as well as evidence for BMP-dependent expression of the latter (for review see [5]). Therefore, when trying to understand BMP function in vivo, it is important to examine BMPs in the context of expression of their antagonists as well as other regulatory molecules.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kishigami S, Mishina Y (2005) BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev 16: 265–278
Ashe HL, Mannervik M, Levine M (2000) Dpp signaling thresholds in the dorsal ectoderm of the Drosophila embryo. Development 127: 3305–3312
Mizutani CM, Nie Q, Wan FY, Zhang YT, Vilmos P, Sousa-Neves R, Bier E, Marsh JL, Lander AD (2005) Formation of the BMP activity gradient in the Drosophila embryo. Dev Cell 8: 915–924
Podos SD, Ferguson EL (1999) Morphogen gradients: New insights from DPP. Trends Genet 15: 396–402
Canalis E, Economides AN, Gazzerro E (2003) Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24: 218–235
Kornak U, Mundlos S (2003) Genetic disorders of the skeleton: A developmental approach. Am J Hum Genet 73: 447–474
Hartung A, Sieber C, Knaus P (2006) Yin and Yang in BMP signaling: Impact on the pathology of diseases and potential for tissue regeneration. Signal Transduction 6: 314–328
Lee SJ (2004) Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 20: 61–86
Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ (1994) Limb alterations in brachypodism mice due to mutations in a new member of the TGF betasuperfamily. Nature 368: 639–643
Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38: 525–527
Cao X, Eu KW, Kumarasinghe MP, Li HH, Loi C, Cheah PY (2006) Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genome-wide highdensity single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function. J Med Genet 43: e13
Gong Y, Krakow D, Marcelino J, Wilkin D, Chitayat D, Babul-Hirji R, Hudgins L, Cremers CW, Cremers FP, Brunner HG et al (1999) Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 21: 302–304
Brown DJ, Kim TB, Petty EM, Downs CA, Martin DM, Strouse PJ, Moroi SE, Gebarski SS, Lesperance MM (2003) Characterization of a stapes ankylosis family with a NOG mutation. Otol Neurotol 24: 210–215
Warren SM, Brunet LJ, Harland RM, Economides AN, Longaker MT (2003) The BMP antagonist noggin regulates cranial suture fusion. Nature 422: 625–629
Kaplan FS, Glaser DL, Shore EM, Pignolo RJ, Xu M, Zhang Y, Senitzer D, Forman SJ, Emerson SG (2007) Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 89: 347–357
Kaplan FS, Shore EM, Gupta R, Billings PC, Glaser DL, Pirgnolo RJ, Graf D, Kamoun M (2005) Immunological features of fibrodysplasia ossificans progressiva and the dysregulated BMP-4 pathway. Clin Rev Bone Miner Metab 3: 189–193
Gautschi OP, Frey SP, Zellweger R (2007) Bone morphogenetic proteins in clinical applications. ANZ J Surg 77: 626–631
Fuller K, Bayley KE, Chambers TJ (2000) Activin A is an essential cofactor for osteoclast induction. Biochem Biophys Res Commun 268: 2–7
Lories RJ, Daans M, Derese I, Matthys P, Kasran A, Tylzanowski P, Ceuppens JL, Luyten FP (2006) Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis. Arthritis Rheum 54: 1736–1746
Zhao GQ (2003) Consequences of knocking out BMP signaling in the mouse. Genesis 35: 43–56
Graf D, Nethisinghe S, Palmer DB, Fisher AG, Merkenschlager M (2002) The developmentally regulated expression of Twisted gastrulation reveals a role for bone morphogenetic proteins in the control of T cell development. J Exp Med 196: 163–171
Adams NC, Gale NW (2006) High Resolution Gene expression analysis in mice using genetically inserted reporter genes. In: S Pease, C Lois (eds): Mammalian and Avian Transgenesis — New Approaches. Springer, Berlin, 131–172
Collins FS, Rossant J, Wurst W (2007) A mouse for all reasons. Cell 128: 9–13
Monteiro RM, de Sousa Lopes SM, Korchynskyi O, ten Dijke P, Mummery CL (2004)Spatio-temporal activation of Smad1 and Smad5 in vivo: Monitoring transcriptional activity of Smad proteins. J Cell Sci 117: 4653–4663
Nohe A, Keating E, Knaus P, Petersen NO (2004) Signal transduction of bone morphogenetic protein receptors. Cell Signal 16: 291–299
Sugimori K, Matsui K, Motomura H, Tokoro T, Wang J, Higa S, Kimura T, Kitajima I (2005) BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/ Akt-mediated NF-kappaB activation. J Bone Miner Metab 23: 411–419
Hager-Theodorides AL, Outram SV, Shah DK, Sacedon R, Shrimpton RE, Vicente A, Varas A, Crompton T (2002) Bone morphogenetic protein 2/4 signaling regulates early thymocyte differentiation. J Immunol 169: 5496–5504
Bachiller D, Klingensmith J, Shneyder N, Tran U, Anderson R, Rossant J, DeRobertis EM (2003) The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome. Development 130: 3567–3578
Ohnemus S, Kanzler B, Jerome-Majewska LA, Papaioannou VE, Boehm T, Mallo M (2002) Aortic arch and pharyngeal phenotype in the absence of BMP-dependent neural crest in the mouse. Mech Dev 119: 127–135
Bleul CC, Boehm T (2005) BMP signaling is required for normal thymus development. J Immunol 175: 5213–5221
Nosaka T, Morita S, Kitamura H, Nakajima H, Shibata F, Morikawa Y, Kataoka Y, Ebihara Y, Kawashima T, Itoh T et al (2003) Mammalian twisted gastrulation is essential for skeleto-lymphogenesis. Mol Cell Biol 23: 2969–2980
de Boer J, Williams A, Skavdis G, Harker N, Coles M, Tolaini M, Norton T, Williams K, Roderick K, Potocnik AJ et al (2003) Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol 33: 314–325
Liston A, Farr AG, Chen Z, Benoist C, Mathis D, Manley NR, Rudensky AY (2007) Lack of Foxp3 function and expression in the thymic epithelium. J Exp Med 204: 475–480
Mass RL, Zeller R, Woychik RP, Vogt TF, Leder P (1990) Disruption of formin-encoding transcripts in two mutant limb deformity alleles. Nature 346: 853–855
Zuniga A, Michos O, Spitz F, Haramis AP, Panman L, Galli A, Vintersten K, Klasen C, Mansfield W, Kuc S et al (2004) Mouse limb deformity mutations disrupt a global control region within the large regulatory landscape required for Gremlin expression. Genes Dev 18: 1553–1564
Khokha MK, Hsu D, Brunet LJ, Dionne MS, Harland RM (2003) Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet 34: 303–307
Long X, Miano JM (2007) Remote control of gene expression. J Biol Chem 282: 15941–15945
Portnoy ME, McDermott KJ, Antonellis A, Margulies EH, Prasad AB, Kingsley DM, Green ED, Mortlock DP (2005) Detection of potential GDF6 regulatory elements by multispecies sequence comparisons and identification of a skeletal joint enhancer. Genomics 86: 295–305
Chandler RL, Chandler KJ, McFarland KA, Mortlock DP (2007) BMP-2 transcription in osteoblast progenitors is regulated by a distant 3′ enhancer located 156.3 kilobases from the promoter. Mol Cell Biol 27: 2934–2951
DiLeone RJ, Marcus GA, Johnson MD, Kingsley DM (2000) Efficient studies of longdistance BMP-5 gene regulation using bacterial artificial chromosomes. Proc Natl Acad Sci USA 97: 1612–1617
DiLeone RJ, Russell LB, Kingsley DM (1998) An extensive 3′ regulatory region controls expression of BMP-5 in specific anatomical structures of the mouse embryo. Genetics 148: 401–408
Ovcharenko I, Nobrega MA, Loots GG, Stubbs L (2004) ECR browser: A tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res 32: W280–286
Winnier G, Blessing M, Labosky PA, Hogan BL (1995) Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9: 2105–2116
Lawson KA, Dunn NR, Roelen BA, Zeinstra LM, Davis AM, Wright CV, Korving JP, Hogan BL (1999) BMP-4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev 13: 424–436
Dunn NR, Winnier GE, Hargett LK, Schrick JJ, Fogo AB, Hogan BL (1997) Haploinsufficient phenotypes in BMP-4 heterozygous null mice and modification by mutations in Gli3 and Alx4. Dev Biol 188: 235–247
Chang B, Smith RS, Peters M, Savinova OV, Hawes NL, Zabaleta A, Nusinowitz S, Martin JE, Davisson ML, Cepko CL et al (2001) Haploinsufficient BMP-4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genet 2: 18
Frank DB, Abtahi A, Yamaguchi DJ, Manning S, Shyr Y, Pozzi A, Baldwin HS, Johnson JE, de Caestecker MP (2005) Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension. Circ Res 97: 496–504
Kulessa H, Hogan BL (2002) Generation of a loxP flanked BMP-4loxP-lacZ allele marked by conditional lacZ expression. Genesis 32: 66–68
Muyrers JP, Zhang Y, Testa G, Stewart AF (1999) Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res 27: 1555–1557
Copeland NG, Jenkins NA, Court DL (2001) Recombineering: A powerful new tool for mouse functional genomics. Nat Rev Genet 2: 769–779
Valenzuela DM, Murphy AJ, Frendewey D, Gale NW, Economides AN, Auerbach W, Poueymirou WT, Adams NC, Rojas J, Yasenchak J et al (2003) High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol 21: 652–659
Gazzerro E, Smerdel-Ramoya A, Zanotti S, Stadmeyer L, Durant D, Economides AN, Canalis E (2007) Conditional deletion of gremlin causes a transient increase in bone formation and bone mass. J Biol Chem 282: 31549–31557
Zhang H, Bradley A (1996) Mice deficient for BMP-2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122: 2977–2986
Correia AC, Costa M, Moraes F, Bom J, Novoa A, Mallo M (2007) BMP-2 is required for migration but not for induction of neural crest cells in the mouse. Dev Dyn 236: 2493–2501
Ma L, Martin JF (2005) Generation of a BMP-2 conditional null allele. Genesis 42: 203–206
Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V (2006) BMP-2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38: 1424–1429
King JA, Marker PC, Seung KJ, Kingsley DM (1994) BMP-5 and the molecular, skeletal, and soft-tissue alterations in short ear mice. Dev Biol 166: 112–122
Solloway MJ, Dudley AT, Bikoff EK, Lyons KM, Hogan BL, Robertson EJ (1998) Mice lacking BMP-6 function. Dev Genet 22: 321–339
Dudley AT, Lyons KM, Robertson EJ (1995) A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9: 2795–2807
Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G (1995) BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9: 2808–2820
Kim RY, Robertson EJ, Solloway MJ (2001) BMP-6 and BMP-7 are required for cushion formation and septation in the developing mouse heart. Dev Biol 235: 449–466
Solloway MJ, Robertson EJ (1999) Early embryonic lethality in BMP-5; BMP-7 double mutant mice suggests functional redundancy within the 60A subgroup. Development 126: 1753–1768
Patel SR, Dressler GR (2005) BMP-7 signaling in renal development and disease. Trends Mol Med 11: 512–518
Godin RE, Takaesu NT, Robertson EJ, Dudley AT (1998) Regulation of BMP-7 expression during kidney development. Development 125: 3473–3482
Brunet LJ, McMahon JA, McMahon AP, Harland RM (1998) Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280: 1455–1457
McMahon JA, Takada S, Zimmerman LB, Fan CM, Harland RM, McMahon AP (1998) Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev 12: 1438–1452
Michos O, Panman L, Vintersten K, Beier K, Zeller R, Zuniga A (2004) Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131: 3401–3410
Bachiller D, Klingensmith J, Kemp C, Belo JA, Anderson RM, May SR, McMahon JA, McMahon AP, Harland RM, Rossant J et al (2000) The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature 403: 658–661
Petryk A, Anderson RM, Jarcho MP, Leaf I, Carlson CS, Klingensmith J, Shawlot W, O’Connor MB (2004) The mammalian twisted gastrulation gene functions in foregut and craniofacial development. Dev Biol 267: 374–386
Gazzerro E, Deregowski V, Stadmeyer L, Gale NW, Economides AN, Canalis E (2006) Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function. Bone 39: 1252–1260
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Graf, D., Economides, A.N. (2008). Dissection of bone morphogenetic protein signaling using genome-engineering tools. In: Vukicevic, S., Sampath, K.T. (eds) Bone Morphogenetic Proteins: From Local to Systemic Therapeutics. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8552-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8552-1_7
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8551-4
Online ISBN: 978-3-7643-8552-1
eBook Packages: MedicineMedicine (R0)